Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 21932124)

1.

A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer.

Rong Y, Qin X, Jin D, Lou W, Wu L, Wang D, Wu W, Ni X, Mao Z, Kuang T, Zang YQ, Qin X.

Clin Exp Med. 2012 Sep;12(3):173-80. doi: 10.1007/s10238-011-0159-0. Epub 2011 Sep 20.

PMID:
21932124
2.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
3.

Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.

DeMatos P, Abdel-Wahab Z, Vervaert C, Hester D, Seigler H.

J Surg Oncol. 1998 Jun;68(2):79-91. Review.

PMID:
9624036
4.

Tumor vaccines for breast cancer.

Anderson KS.

Cancer Invest. 2009 May;27(4):361-8. doi: 10.1080/07357900802574421. Review. No abstract available.

5.

ELISpot for measuring human immune responses to vaccines.

Slota M, Lim JB, Dang Y, Disis ML.

Expert Rev Vaccines. 2011 Mar;10(3):299-306. doi: 10.1586/erv.10.169. Review.

6.

Novel pancreatic cancer vaccines could unleash the army within.

Springett GM.

Cancer Control. 2014 Jul;21(3):242-6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk